🇺🇸 Intranasal ketamine in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Agitation — 1 report (10%)
  2. Angioedema — 1 report (10%)
  3. Application Site Pain — 1 report (10%)
  4. Delusion — 1 report (10%)
  5. Depression — 1 report (10%)
  6. Disinhibition — 1 report (10%)
  7. Dissociation — 1 report (10%)
  8. Drug Ineffective — 1 report (10%)
  9. Hallucination, Visual — 1 report (10%)
  10. Hypertension — 1 report (10%)

Source database →

Other Psychiatry / Pain Management approved in United States

Frequently asked questions

Is Intranasal ketamine approved in United States?

Intranasal ketamine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Intranasal ketamine in United States?

Rhode Island Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.